Immunotherapeutic Strategies Targeting GD2-Expressing Malignancies
Adv Exp Med Biol. 2026;1491:537-563. doi: 10.1007/978-3-032-04153-1_31. ABSTRACT GD2, a tumor-associated carbohydrate antigen, has been validated as a promising immunotherapeutic target for the treatment of …